Cravath’s New York Office Moves to Two Manhattan West
Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Education
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
Admitted In
- New York
Professional Affiliations
International Bar Association
Rankings
Best Lawyers in America
- Securities/Capital Markets Law (2025-2019)
Chambers Global
- Capital Markets: Debt & Equity - USA (2025‑2011)
Chambers USA
- Capital Markets: Debt & Equity - Nationwide (2024‑2012)
IFLR1000
- Capital Markets - US (2024‑2011)
Latin Lawyer 250: Latin America’s Leading Business Law Firms
- Banking & Finance - International (2020)
- Capital Markets - International (2020, 2019, 2018, 2016‑2010)
- Corporate and M&A - International (2016)
Lawdragon
- 500 Leading Dealmakers in America (2024-2021)
The Legal 500 Hall of Fame
- Capital Markets: Debt Offerings
- Capital Markets: High‑Yield Debt Offerings
The Legal 500 Latin America
- Capital Markets - Latin America: International Firms (2019, 2014, 2013, 2012)
- Corporate and M&A - Latin America: International Firms (2017, 2016, 2013, 2012)
The Legal 500 US
- Capital Markets: Debt Offerings (2024‑2009)
- Capital Markets: Equity Offerings (2024-2019, 2016, 2015, 2013, 2012)
- Capital Markets: Global Offerings (2024-2018, 2016‑2010)
- Capital Markets: High‑Yield Debt Offerings (2024‑2009)
- Telecoms and Broadcast: Transactions (2016‑2010)
Deals & Cases
March 14, 2025
State Street Corporation’s $2.75 Billion Registered Senior Notes and Fixed‑to‑Floating Rate Senior Notes Offering
Cravath represented the underwriters in connection with the $2.75 billion registered senior notes and fixed‑to‑floating rate senior notes offering of State Street Corporation, a provider of a broad range of financial products and services to institutional investors worldwide. The transaction closed on February 28, 2025.
Deals & Cases
March 12, 2025
Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
Deals & Cases
March 11, 2025
Kraft Heinz Foods Company’s $1 Billion Registered Senior Notes Offering and Concurrent Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of Kraft Heinz Foods Company, one of the largest food and beverage companies in the world at the time of the offering. Cravath also represented the underwriters in connection with Kraft Heinz Foods Company’s concurrent €600 million registered senior notes offering. The transactions closed on February 25, 2025.
Deals & Cases
March 06, 2025
The State of Israel’s $5 Billion Registered Notes Offering
Cravath represented the underwriters in connection with the $5 billion registered notes offering of the State of Israel. The notes were listed on the London Stock Exchange. The transaction closed on February 19, 2025.
Deals & Cases
February 27, 2025
Union Pacific Corporation’s $2 Billion Registered Notes Offering
Cravath represented the underwriters in connection with the $2 billion registered notes offering of Union Pacific Corporation, owner of one of America's leading transportation companies. The transaction closed on February 13, 2025.
Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Education
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
Admitted In
- New York
Professional Affiliations
International Bar Association
Rankings
Best Lawyers in America
- Securities/Capital Markets Law (2025-2019)
Chambers Global
- Capital Markets: Debt & Equity - USA (2025‑2011)
Chambers USA
- Capital Markets: Debt & Equity - Nationwide (2024‑2012)
IFLR1000
- Capital Markets - US (2024‑2011)
Latin Lawyer 250: Latin America’s Leading Business Law Firms
- Banking & Finance - International (2020)
- Capital Markets - International (2020, 2019, 2018, 2016‑2010)
- Corporate and M&A - International (2016)
Lawdragon
- 500 Leading Dealmakers in America (2024-2021)
The Legal 500 Hall of Fame
- Capital Markets: Debt Offerings
- Capital Markets: High‑Yield Debt Offerings
The Legal 500 Latin America
- Capital Markets - Latin America: International Firms (2019, 2014, 2013, 2012)
- Corporate and M&A - Latin America: International Firms (2017, 2016, 2013, 2012)
The Legal 500 US
- Capital Markets: Debt Offerings (2024‑2009)
- Capital Markets: Equity Offerings (2024-2019, 2016, 2015, 2013, 2012)
- Capital Markets: Global Offerings (2024-2018, 2016‑2010)
- Capital Markets: High‑Yield Debt Offerings (2024‑2009)
- Telecoms and Broadcast: Transactions (2016‑2010)
Deals & Cases
March 14, 2025
State Street Corporation’s $2.75 Billion Registered Senior Notes and Fixed‑to‑Floating Rate Senior Notes Offering
Cravath represented the underwriters in connection with the $2.75 billion registered senior notes and fixed‑to‑floating rate senior notes offering of State Street Corporation, a provider of a broad range of financial products and services to institutional investors worldwide. The transaction closed on February 28, 2025.
Deals & Cases
March 12, 2025
Johnson & Johnson’s $5 Billion Registered Notes Offering and Concurrent €4 Billion Notes Offering
Cravath represented the underwriters in connection with the $5 billion registered notes offering of Johnson & Johnson, the world’s largest, most diversified healthcare products company. Cravath also represented the underwriters in connection with Johnson & Johnson’s concurrent €4 billion notes offering. Proceeds of both offerings will be used to finance the acquisition of Intra‑Cellular Therapies, Inc. by Johnson & Johnson. The transactions closed on February 20, 2025, and February 26, 2025, respectively.
Deals & Cases
March 11, 2025
Kraft Heinz Foods Company’s $1 Billion Registered Senior Notes Offering and Concurrent Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of Kraft Heinz Foods Company, one of the largest food and beverage companies in the world at the time of the offering. Cravath also represented the underwriters in connection with Kraft Heinz Foods Company’s concurrent €600 million registered senior notes offering. The transactions closed on February 25, 2025.
Deals & Cases
March 06, 2025
The State of Israel’s $5 Billion Registered Notes Offering
Cravath represented the underwriters in connection with the $5 billion registered notes offering of the State of Israel. The notes were listed on the London Stock Exchange. The transaction closed on February 19, 2025.
Deals & Cases
February 27, 2025
Union Pacific Corporation’s $2 Billion Registered Notes Offering
Cravath represented the underwriters in connection with the $2 billion registered notes offering of Union Pacific Corporation, owner of one of America's leading transportation companies. The transaction closed on February 13, 2025.
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.